RSV subunit vaccine (Wuhan Institute of Virology)

N/A

Report date: 2025/03/19 11:45:16

Base Information

Drug NameRSV subunit vaccine (Wuhan Institute of Virology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionRespiratory syncytial virus F protein stimulants
TargetsRespiratory syncytial virus F protein
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuhan Institute Of Virology, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Institute Of Virology, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A